Close Menu

In this week's Science Translational Medicine, an international research team reports the identification of two proteins that may help treat muscular dystrophy. Nearly half of all cases of the disease are caused by mutations in the LAMA2 gene, but gene replacement therapies have been ineffective for these cases because of the amount of proteins required to restore muscle functionality.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.